Vaccines 2020: World Market Analysis, Players, Trends

    Published: November 4, 2020 | Price: $4,000.00 – $8,000.00

    Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION  The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000.00 – $8,000.00

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000.00 – $6,000.00

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...
    The Worldwide Market for Laboratory-Developed Tests (LDTs)

    Published: September 24, 2020 | Price: $5,500.00 – $11,000.00

    Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically.  Historically, these tests were called “home-brew tests” or “in-house tests.”  Also, historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications.  Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians...
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)

    Published: September 18, 2020 | Price: $5,500.00 – $11,000.00

    What is the Market for Urgent Care Centers?  What Services are they Selling?  Who is Selling Testing and Vaccine Products to Urgent Care? Kalorama's comprehensive report answers these questions, and more. With approximately 10,000 locations across the country, urgent care clinics (UCCs), are an increasingly important of the U.S. health care marketplace. They offer walk-in care and a range of services, expanded hours and limited wait times.  Urgent care centers are not new. There are many urgent care centers in operation...
    The Market for RNA Sequencing

    Published: August 24, 2020 | Price: $5,500.00 – $11,000.00

    The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...
    The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition

    Published: July 31, 2020 | Price: $8,250.00 – $16,500.00

    Download Brochure What is the Size of the IVD Market in 2020? In its latest report Kalorama Information estimates the market for in vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars.   This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVD-19 testing responsible for most of the growth.  Other infectious diseases (particularly respiratory pathogens), advanced cancer IVDs and increasing used of critical care...
    Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience

    Published: July 27, 2020 | Price: $3,750.00 – $7,000.00

    Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2020 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors, clinical...
    Digital Pathology: Markets, Trends, Companies and COVID-19 Impact

    Published: July 24, 2020 | Price: $3,500.00 – $7,000.00

    Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms.  Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks.  This allows independent viewing of images by large numbers of people in diverse locations. Digital camera equipped microscopes may zoom onto a specific region on a slide to provide higher resolution of the area.  In another strategy,...
    Molecular Diagnostics Markets in the COVID-19 Era (Markets for COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)

    Published: July 9, 2020 | Price: $5,500.00 – $11,000.00

    Molecular Diagnostics could be said to be the most important part of in vitro diagnostics.  This is especially true in the wake of COVID-19.  Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a year of growth and...
    Clinical Diagnostics MasterFile

    Published: August 30, 2021 | Price:

    More than 42,000 Instruments at over 5,000 Facilities across a Dozen Modalities — 12 Month License with Quarterly Refresh Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation HbA1c Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture Molecular Diagnostics Next-Generation Sequencing Urinalysis Analyzers...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Emerging Infectious Disease Diagnostics: Markets and Trends

    Published: May 27, 2020 | Price: $3,000.00 – $6,000.00

    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
    Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

    Published: May 19, 2020 | Price: $5,000.00 – $10,000.00

    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...
    Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

    Published: May 14, 2020 | Price: $4,000.00 – $8,000.00

    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...